Pulse Biosciences is developing nsPFA technology for cardiac ablation to treat AFib and for ablating benign thyroid nodules.

Abbott designed the Volt PFA catheter for maneuverability, efficient ablation and thermal risk mitigation, said Dr.

“The locations of the ablation lines have been standardized over years of research and evaluation,” says Matthew Henn, MD, a cardiac surgeon and assistant professor of surgery at The Ohio ...

A novel diffusion model generates synthetic atrial fibrosis images to augment data for deep learning, improving prediction of ...

Johnson & Johnson’s electrophysiology unit struggled in the first quarter, as the company chases Medtronic and Boston ...

One of AI’s most immediate impacts is in screening and identifying patients who may have asymptomatic or paroxysmal AF, those ...

LA Chargers coach Jim Harbaugh is having a cardiac ablation during the offseason. It's a procedure to treat an irregular heart rhythm. The procedure involves creating tiny scars in the heart that ...

Imricor Medical Systems announced that it commenced a trial by completing its first-in-human ventricular ablation procedure.

Special Report: Imricor Medical Systems has secured CE Mark certification for its Advantage-MR system under the European ...

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that it has ...